SCS Capital Management’s Colgate-Palmolive CL Stock Holding History

SCS Capital Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.13M	Buy	23,198 +3,947	+21%	+$345K	0.02%	215
2026 Q1	$1.64M	Sell	19,251 -1,500	-7%	-$134K	0.02%	219
2025 Q4	$1.64M	Sell	20,751 -530	-2%	-$41.6K	0.02%	233
2025 Q3	$1.7M	Buy	21,281 +404	+2%	+$34.5K	0.02%	229
2025 Q2	$1.9M	Sell	20,877 -207	-1%	-$18.9K	0.02%	228
2025 Q1	$1.98M	Buy	+21,084	New	+$1.89M	0.03%	202

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

SCS Capital Management's CL Position: Q2 2026 in Review

SCS Capital Management increased its Colgate-Palmolive (CL) stake by 21% in Q2 2026, buying an estimated $345K and bringing the position to 23,198 shares worth $2.13M. The position accounts for 0.02% of the portfolio, ranked #215.

SCS Capital Management first reported a position in CL in Q1 2025 and has held it in 6 quarters since. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

SCS Capital Management held 23,198 shares of Colgate-Palmolive worth $2.13M as of Q2 2026.
SCS Capital Management bought 3,947 Colgate-Palmolive shares in Q2 2026, an estimated $345K.
Colgate-Palmolive made up 0.02% of SCS Capital Management's portfolio in Q2 2026, its #215 holding.
SCS Capital Management first reported a position in Colgate-Palmolive in Q1 2025 and has held it in 6 quarters since.
2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on SCS Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.